For research purposes only. Not for human consumption. For use by licensed researchers only.
The BPC-157 / TB-500 Blend combines two of the most extensively researched regenerative peptides — Body Protection Compound-157 and the Thymosin Beta-4 43AA fragment — into a single research formulation. This combination is studied for synergistic effects on tissue repair, inflammation resolution, and multi-system recovery.
Mechanism of Action
BPC-157 promotes angiogenesis, fibroblast migration, and growth hormone receptor upregulation via the VEGF pathway, while TB-500 upregulates actin to accelerate cell movement and mobilize stem cells to injury sites. Research suggests this dual mechanism addresses tissue regeneration from complementary angles, potentially accelerating healing cascades more effectively than either compound alone.
Research Applications
- Synergistic tendon, ligament, and muscle repair research
- Combined wound healing and angiogenesis studies
- Multi-pathway anti-inflammatory investigation
- Post-injury tissue regeneration models
- Gut and systemic cytoprotection research
Research Grade Peptide
| Compound | BPC-157 / TB-500 Blend |
| Strength | 10 mg / 10 mg |
| Vial Size | 3 mL |
| Vial Color | Clear |
| Form | Lyophilized Powder |
| Purity | >98% (HPLC verified) |
| Price | $180.00 |
This compound is provided strictly for in vitro and laboratory research. It has not been evaluated by the FDA and is not intended for diagnostic, therapeutic, or human use. Available to licensed researchers only.